EVONIK INDUST.(U.ARD)2

Research EVONIK INDUST.(U.ARD)2 (EVKA) on Bullrun: valuation model: 32.1% overvalued, market cap EUR 7.04B, P/E 44.4, dividend yield 6.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks EVONIK INDUST.(U.ARD)2 as 32.1% overvalued; latest market cap is EUR 7.04B; P/E is 44.4; dividend yield is 6.7%.

About EVONIK INDUST.(U.ARD)2

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries;

Frequently asked questions

Is EVONIK INDUST.(U.ARD)2 overvalued or undervalued?

Bullrun's valuation model currently marks EVONIK INDUST.(U.ARD)2 as 32.1% overvalued.

What is EVONIK INDUST.(U.ARD)2's market cap?

EVONIK INDUST.(U.ARD)2's market capitalization is EUR 7.04B.

What is EVONIK INDUST.(U.ARD)2's P/E ratio?

EVONIK INDUST.(U.ARD)2's price-to-earnings (P/E) ratio is 44.4.

Does EVONIK INDUST.(U.ARD)2 pay a dividend?

EVONIK INDUST.(U.ARD)2 has a dividend yield of 6.7%.

What does EVONIK INDUST.(U.ARD)2 do?

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications;